Rpg Investment Advisory, LLC Vertex Pharmaceuticals Inc Transaction History

Rpg Investment Advisory, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 06, 2018	SELL	$145.72 - $169.96 $1.43 Million - $1.66 Million	-9,785 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$151.6 - $177.13 $197,838 - $231,154	-1,305 Reduced 11.77%	9,785 $1.6 Million
Q4 2017 Feb 14, 2018	SELL	$137.28 - $155.55 $19,219 - $21,777	-140 Reduced 1.25%	11,090 $1.66 Million
Q3 2017 Feb 05, 2019	SELL	$148.13 - $162.24 $25,182 - $27,580	-170 Reduced 1.49%	11,230 $1.71 Million
Q2 2017 Feb 04, 2019	BUY	N/A	11,400	11,400 $1.47 Million

1,745

227M

1.53M

1.4M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $118B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Rpg Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Rpg Investment Advisory, LLC with notifications on news.